Allan, C. A. (1995). Alcohol problems and anxiety disorders — A critical review. Alcohol & Alcoholism, 30(2), 145–151.

American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington DC: American Psychiatric Association.

Andreasson, S., Allebeck, P., & Rydberg, U. (1987). Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet, 2, 1483-1486.

Andrews, G. (1996). Comorbidity and the general neurotic syndrome. British Journal of Psychiatry — Supplement (30), 76–84.

Andrews, G., Henderson, S., & Hall, W. (2001). Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. British Journal of Psychiatry, 178, 145–153.

Andrews, G., Stewart, G., Allen, R., & Henderson, A. S. (1990). The genetics of six neurotic disorders: a twin study. Journal of Affective Disorders, 19(1), 23–29.

Angold, A., Costello, E. J., & Erkanli, A. (1999). Comorbidity. Journal of Child Psychology and Psychiatry, 40(1), 57–87.

Berkson, J. (1946). Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin, 2, 47–53.

Bijl, R.V., Ravelli, A., & van Zessen, G. (1998). Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social Psychiatry and Psychiatric Epidemiology, 33(12), 587–595.

Blanchard, J. J., Brown, S. A., Horan, W. P., & Sherwood, A. R. (2000). Substance Use Disorders in Schizophrenia: Review, integration, and a proposed model. Clinical Psychology Review, 20(2), 207–234.

Bland, R., Newman, S., & Orn, H. (1988). Epidemiology of psychiatric disorders in Edmonton, Canada. Acta Psychiatrica Scandinavica, 77(supp 376), 1–80.

Blazer, D. (1995). Mood disorders: Epidemiology. In H. Kaplan & B. Sadock (Eds.), Comprehensive Textbook of Psychiatry (IV ed., Vol. I, pp. 1079-1089). Baltimore, MA: Williams and Wilkins.

Boyd, J. H., Burke, J. D., Gruenberg, E., et al., (1984). Exclusion criteria of DSM-III: A study of co-occurrence of hierarchy-free syndromes. Archives of General Psychiatry, 41, 983–989.

Brown, S., & Schuckit, M. (1988). Changes in depression amongst abstinent alcoholics. Journal of Studies in Alcohol, 52, 37–43.Top of page

Brugha, T. S., Bebbington, P. E., Jenkins, R., Meltzer, H., Taub, N. A., Janas, M., & Vernon, J. (1999). Cross validation of a general population survey diagnostic interview: a comparison of CIS-R with SCAN ICD-10 diagnostic categories. Psychological Medicine, 29(5), 1029–1042.

Cappell, H., & Greeley, J. (1987). Alcohol and tension reduction: An update on research and theory. In H.T. Blane & K. E. Leonard (Eds.), Psychological theories of drinking and alcoholism (pp. 15–54). London: Guilford Press.

Carey, M., Carey, K., & Meisler, A. (1991). Psychiatric symptoms in mentally ill chemical abusers. Journal of Nervous and Mental Disease, 179, 136–138.

Caron, C., & Rutter, M. (1991). Comorbidity in child psychopathology: Concepts, issues and research strategies. Journal of Child Psychology and Psychiatry, 32(2), 1063–1080.

Dixon, L., Haas, G., Weiden, P., Sweeney, J., & Frances, A. (1991). Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. American Journal of Psychiatry, 148(2), 224–230.

Doris, A., Ebmeier, K., & Shajahan, P. (1999). Depressive illness. Lancet, 354(9187), 1369–1375.

Eysenck, H. J., & Eysenck, S. B. G. (1991). Manual of the Eysenck Personality Scales (EPS Adult). London: Hodder & Stoughton.

Farrell, M., Howes, S., Taylor, C., Lewis, G., Jenkins, R., Bebbington, P., Jarvis, M., Brugha, T., Gill, B., & Meltzer, H. (1998). Substance misuse and psychiatric comorbidity: An overview of the OPCS National Psychiatric Morbidity Survey. Addictive Behaviours, 32(6), 909–918.

Feinstein, A. R. (1970). The pre-therapeutic classification of comorbidity in chronic disease. Journal of Chronic Diseases, 23, 455–468.

Fergusson, D., Horwood, J., & Lawton, M. (1990).Vulnerability to childhood problems and family social background. Journal of Child Psychology and Psychiatry, 31, 1145–1160

Fergusson, D., Horwood, L., & Lynskey, M. (1994). Parental separation, adolescent psychopathology and problem behaviours. Journal of the American Academy of Child and Adolescent Psychology, 33, 1122–1131.

Fergusson, D. M., & Horwood, L. J. (1997). Early onset cannabis use and psychosocial adjustment in young adults. Addiction, 92(3), 279–296.

Fergusson, D. M., & Horwood, L. J. (2000). Does cannabis use encourage other forms of illicit drug use? Addiction, 95(4), 505–520.

Fergusson, D. M., Lynskey, M.T., & Horwood, L. J. (1996). Comorbidity between depressive disorders and nicotine dependence in a cohort of 16-year-olds. Archives of General Psychiatry, 53(11), 1043–1047.

Fichter, M. M., Narrow, W. E., Roper, M.T., Rehm, J., Elton, M., Rae, D., Locke, B., & Regier, D. (1996). Prevalence of mental illness in Germany and the United States: Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area program. Journal of Nervous and Mental Disease, 184(10), 598–606.Top of page

Folstein, M., Romanoski, A., Chahal, R., Athnoy, J., VonKorff, M., Nestadt, G., Merchant, A., Gruenberg, E., & Kramer, M. (1985). Eastern Baltimore Mental Health Survey clinical appraisal. In W. Eaton & L. Kessler (Eds.), Epidemiologic field methods in psychiatry: The NIMH Epidemiologic Catchment Area program (pp. 253-284). Orlando, FL: Academic Press.

Francis, L. (1996). The relationship between Eysenck's personality factors and attitude towards substance use among 13-15 year olds. Personality and Individual Differences, 21(5), 633–640.

Galbaud Du Fort, G., Newman, S., & Bland, R. (1993). Psychiatric comorbidity and treatment seeking: Sources of selection bias in the study of clinical populations. Journal of Nervous and Mental Disease, 181(8), 464–474.

Gilbert, D. G., & Gilbert, B. O. (1995). Personality, psychopathology and nicotine response as mediators of the genetics of smoking. Behavior Genetics, 25(2), 133–147.

Grant, B. F., & Pickering, R. (1998). The relationship between cannabis use and DSM-IV cannabis abuse and dependence: Results from the national longitudinal alcohol epidemiologic survey. Journal of Substance Abuse, 10(3), 255–264.

Hall, S., Reus, V., Munoz, R., Sees, K., Humfleet, G., Hartz, D., Frederick, S., & Triffleman, S. (1998). Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking. Archives of General Psychiatry, 55(8), 683–690.

Hall, W. (1998). Cannabis use and psychosis. Drug and Alcohol Review, 17, 433–444.

Hall, W., & Degenhardt, L. (2000). Cannabis use and psychosis: A review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry, 34, 26–34.

Hall, W., Teesson, M., Lynskey, M., & Degenhardt, L. (1999). The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Wellbeing. Addiction, 94(10), 1541–1550.

Haywood, T.W., Kravitz, H. M., Grossman, L. S., Cavanaugh, J. L., Jr., Davis, J. M., & Lewis, D. A. (1995). Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry, 152(6), 856–861.

Helzer, J., Stolzman, R., Farmer, A., Brochington, I., Plesons, D., Singerman, B., & Works, J. (1985). Comparing the DIS with a DIS/DSM-III based physician re-evaluation. In W. Eaton & L. Kessler (Eds.), Epidemiologic field methods in psychiatry: The NIMH Epidemiologic Catchment Area program (pp. 285-308). Orlando, FL: Academic Press.

Henderson, S., Andrews, G., & Hall, W. (2000). Australia's mental health: An overview of the general population survey. Australian and New Zealand Journal of Psychiatry, 34, 197–205.

Holzer, C., Spitznagel, E., Jordan, K., Timbers, D., Kessler, L., & Anthony, J. (1985). Sampling the household population. In W. Eaton & L. Kessler (Eds.), Epidemiologic field methods in psychiatry: The NIMH Epidemiologic Catchment Area program (pp. 285–308). Orlando, FL: Academic Press.

Hwu, H. G., Yeh, E. K., & Chang, L.Y. (1989). Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatrica Scandinavica, 79(2), 136–147.Top of page

Institute of Medicine. (1996). Pathways of addiction. Washington: National Academy Press.

Iqbal, N., & van Praag, H. M. (1995). The role of serotonin in schizophrenia. European Neuropsychopharmacology, 5(Suppl), 11–23.

Jablensky, A., Sartorius, N., & Ernberg, G. (1991). Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization Ten-Country Study. Psychological Medicins Supplement No. 20.

Jenkins, R., Bebbington, P., Brugha, T., Farrell, M., Gill, B., Lewis, G., Meltzer, H., & Petticrew, M. (1997). The National Psychiatric Morbidity Surveys of Great Britain — strategy and methods. Psychological Medicine, 27(4), 765-774.

Jenkins, R., Lewis, G., Bebbington, P., Brugha, T., Farrell, M., Gill, B., & Meltzer, H. (1997). The National Psychiatric Morbidity surveys of Great Britain — initial findings from the household survey. Psychological Medicine, 27(4), 775–789.

Kandel, D., & Faust, R. (1975). Sequence and stages in patterns of adolescent drug use. Archives of General Psychiatry, 32, 923–932.

Kandel, D. B.,Yamaguchi, K., & Chen, K. (1992). Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. Journal of Studies on Alcohol, 53(5), 447–457.

Kendler, K., Neale, M., MacLean, C., Heath, A., Eaves, L., & Kessler, R. (1993). Smoking and major depression: A causal analysis. Archives of General Psychiatry, 50(1), 36–43.

Kendler, K. S. (1998). Anna-Monika-Prize paper. Major depression and the environment: a psychiatric genetic perspective. Pharmacopsychiatry, 31(1), 5–9.

Kendler, K. S., Kessler, R. C., Walters, E. E., MacLean, C., Neale, M. C., Heath, A. C., & Eaves, L. J. (1995). Stressful life events, genetic liability, and onset of an episode of major depression in women. American Journal of Psychiatry, 152(6), 833–842.

Kendler, K. S., Neale, M., Kessler, R., Heath, A., & Eaves, L. (1993). A twin study of recent life events and difficulties. Archives of General Psychiatry, 50(10), 789–796.

Kessler, R. (1994a). Building on the ECA: The National Comorbidity Survey and the Children's ECA. International Journal of Methods in Psychiatric Research, 4, 81–94.

Kessler, R. (1994b). The National Comorbidity Survey of the United States. International Review of Psychiatry, 6, 365–376.

Kessler, R. C. (1995). Epidemiology of psychiatric comorbidity. In M.T. Tsuang & M. Tohen & G. E. P. Zahner (Eds.), Textbook in Psychiatric Epidemiology (pp. 179–197). New York: Wiley and Sons.

Kessler, R. C., Foster, C. L., Saunders, W. B., & Stang, P. E. (1995). Social consequences of psychiatric disorders, I: Educational attainment. American Journal of Psychiatry, 152(7), 1026–1032.Top of page

Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., Wittchen, H. U., & Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8–19.

Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry, 142(11), 1259–1264.

Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244.

Koob, G., & Moal, M. L. (1997). Drug Abuse: hedonic homeostatic dysregulation. Lancet, 278, 52–58.

Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24(2), 97–129.

Krishnan-Sarin, S., Rosen, M., & O'Malley, S. (1999). Preliminary Evidence of an Opioid Component in Nicotine Dependence. Archives of General Psychiatry, 56, 663–668.

Lee, C. (1992). Alcoholism in Korea. In J. Helzer & G. Canino (Eds.), Alcoholism in North America, Europe and Asia (pp. 247–263). New York: Oxford University Press.

Lynskey, M.T. (1998). The comorbidity of alcohol dependence and affective disorders: treatment implications. Drug & Alcohol Dependence, 52(3), 201–209.

Lynskey, M.T., Fergusson, D. M., & Horwood, L. J. (1998). The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. Journal of Child Psychology and Psychiatry, 39(7), 995–1005.

Marshall, J. R. (1997). Alcohol and substance abuse in panic disorder. Journal of Clinical Psychiatry, 58(Suppl 2), 46-49; discussion 49–50.

McEvoy, J., & Brown, S. (1999). Smoking in first-episode patients with schizophrenia. American Journal of Psychiatry, 156, 1120A–1121.

McKay, D. R., & Tennant, C. C. (2000). Is the grass greener? The link between cannabis and psychosis. Medical Journal of Australia, 172(6), 284–286.

Mueser, K.T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: a review of etiological theories. Addictive Behaviors, 23(6), 717–734.

Neugebauer, R. (1999). Mind matters: the importance of mental disorders in public health's 21st century mission. American Journal of Public Health, 89(9), 1309–1311.

Noordsy, D. L., Drake, R. E., Teague, G. B., Osher, F. C., Hurlbut, S. C., Beaudett, M. S., & Paskus, T. S. (1991). Subjective experiences related to alcohol use among schizophrenics. Journal of Nervous & Mental Disease, 179(7), 410–414.Top of page

Nutt, D. (1997). The neurochemistry of addiction. Human Psychopharmacology, 12, s53–s58.

Oakley-Browne, M. A., Joyce, P. R., Wells, J. E., Bushnell, J. A., & Hornblow, A. R. (1989). Christchurch Psychiatric Epidemiology Study, Part II: Six month and other period prevalences of specific psychiatric disorders. Australian & New Zealand Journal of Psychiatry, 23(3), 327–340.

O'Donnell, J. A., & Clayton, R. R. (1982). The stepping stone hypothesis — marijuana, heroin and causality. Chemical Dependencies, 4, 229–241.

Orvaschel, H., Leaf, P., Weissman, M., Holzer, C., Tischler, G., & Myers, J. (1985). The Yale-ECA concordance study: A comparison of the DIS and the SADS-L. In W. Eaton & L. Kessler (Eds.), Epidemiologic field methods in psychiatry: The NIMH Epidemiologic Catchment Area program (pp. 235–252). Orlando, FL: Academic Press.

Pope, H. (1979). Drug abuse and psychopathology. New England Journal of Medicine, 301, 1341–1342.

President's Commission on Mental Health. (1978). Report to the President from the President's Commission on Mental Health (Vol. 1. Stock No. 040-000-00390-8).Washington, DC: US Government Printing Office.

Pristach, C., & Smith, C. (1990). Medication compliance and substance abuse among schizophrenic patients. Hospital and Community Psychiatry, 41(12), 1345–1348.

Regier, D., & Kaelber, C. (1995). The Epidemiological Catchment Area (ECA) program: Studying the prevalence and incidence of psychopathology. In M. Tsuang & M. Tohen & G. Zahner (Eds.), Textbook in psychiatric epidemiology (pp. 135–155). New York: John Wiley & Sons.

Regier, D., & Robins, L. (1991). Introduction. In L. Robins & D. Regier (Eds.), Psychiatric Disorders in America: The Epidemiological Catchment Area study (pp. 1–10). New York: The Free Press.

Robins, L., Helzer, J., Croughan, J., & Ratcliff, K. (1981). National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics and validity. Archives of General Psychiatry, 38, 381–389

Robins, L., Helzer, J. E., Croughan, J., Williams, J. B.W., & Spitzer, R. L. (1981). The NIMH diagnostic interview schedule, version III. Washington (DC): US Public Health.

Robins, L. N., & Regier, D. A. (Eds.). (1991). Psychiatric disorders in America: The Epidemiological Catchment Area study. New York: The Free Press.

Ross, H. (1995). DSM-III-R alcohol abuse and dependence and psychiatric comorbidity in Ontario: results from the Mental Health Supplement to the Ontario Health Survey. Drug and Alcohol Dependence, 39, 111–128.

Rouillon, F. (1996). Epidemiology of panic disorder. Encephale, 22 (SPEC. ISS. 5), 25–34.

Rutter, M. (1987). Parental mental disorder as a psychiatric risk factor. In R. Hales & A. Frances (Eds.), Psychiatric Update: American Psychiatric Association: Annual Review (Volume No. 6, pp 647–663).Washington: American Psychiatric Press.

Schuckit, M. A., Tipp, J. E., Bergman, M., Reich, W., Hesselbrock, V. M., & Smith, T. L. (1997). Comparison of induced and independent major depressive disorders in 2,945 alcoholics. American Journal of Psychology, 154(7), 948–957.

Schuckit, M. A., Tipp, J. E., Bucholz, K. K., Nurnberger, J. I., Hesselbrock, V. M., Crowe, R. R., & Kramer, J. (1997). The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction, 92(10), 1289–1304.Top of page

Solomons, K., Neppe, V. M., & Kuyl, J. M. (1990).Toxic cannabis psychosis is a valid entity. South African Medical Journal, 78, 476–481.

Stockwell, T., & Bolderston, H. (1987). Alcohol and phobias. British Journal of Addiction, 82(9), 971–979.

Stockwell, T., Hodgson, R., & Rankin, H. (1982).Tension reduction and the effects of prolonged alcohol consumption. British Journal of Addiction, 77(1), 65–73.

Tambs, K., Harris, J. R., & Magnus, P. (1997). Genetic and environmental contributions to the correlation between alcohol consumption and symptoms of anxiety and depression: Results from a bivariate analysis of Norwegian twin data. Behavior Genetics, 27(3), 241–250.

Thornicroft, G. (1990). Cannabis and psychosis. Is there epidemiological evidence for an association? [erratum appears in Br J Psychiatry 1990 Sep; 157:460]. British Journal of Psychiatry, 157, 25–33.

Thornicroft, G., Meadows, G., & Politi, P. (1992). Is "cannabis psychosis" a distinct category? European Psychiatry, 7(6), 277–282.

Tollefson, G. D. (1991). Anxiety and alcoholism: a serotonin link. British Journal of Psychiatry — Supplementum (12), 34–39.

True, W., Xian, H., Scherrer, J., Madden, P., Bucholz, K., Heath, A., Eisen, S., Lyons, M., Goldberg, J., & Tsuang, M. (1999). Common genetic vulnerability for nicotine and alcohol dependence. Archives of General Psychiatry, 56, 655–661.

Tsuang, M.T., Lyons, M. J., Meyer, J. M., Doyle, T., Eisen, S. A., Goldberg, J., True, W., Lin, N., Toomey, R., & Eaves, L. (1998). Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities [see comments]. Archives of General Psychiatry, 55(11), 967–972.

Velez, C., Johnson, J., & Cohen, P. (1989). A longitudinal analysis of selected risk factors for childhood psychopathology. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 861–864.

Wang, C.-H., Liu, W., Zhang, M.-Y., Yu, E., Xia, Z.-Y., Fernandez, M., Lung, C.-T., Xu, C.-L., & Qu, G.-Y. (1992). Alcohol use, abuse and dependency in Shanghai. In J. Helzer & G. Canino (Eds.), Alcoholism in North America, Europe and Asia (pp. 264–288). New York: Oxford University Press.

Warner, R., Taylor, D., Wright, J., Sloat, A., Springett, G., Arnold, S., & Weinberg, H. (1994). Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. American Journal of Orthopsychiatry, 64(1), 30–39.

Weissman, M., Livingston Bruce, M., Leaf, P., Flroio, L., & Holzer, C. (1991). Affective Disorders. In L. Robins & D. Regier (Eds.), Psychiatric Disorders in America (pp. 53–80). New York: MacMillan.

Wells, J. E., Bushnell, J. A., Hornblow, A. R., Joyce, P. R., & Oakley-Browne, M. A. (1989). Christchurch Psychiatric Epidemiology Study, Part I: Methodology and lifetime prevalence for specific psychiatric disorders. Australian & New Zealand Journal of Psychiatry, 23(3), 315–326.Top of page

Wittchen, H.-U. (1996). Critical issues in the evaluation of comorbidity of psychiatric disorders. British Journal of Psychiatry, 168 (suppl. 30), 9–16.

Wittchen, H.-U., Essau, C. A., von Zerssen, D., Krieg, J. C., & Zaudig, M. (1992). Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study. European Archives of Psychiatry & Clinical Neuroscience, 241(4), 247–258.

World Health Organisation. (1993). The ICD-10 Classification of Mental and Behavioural Disorders — Diagnostic Criteria for Research. Geneva: World Health Organisation.